Fig. 6From: Cost-effectiveness of dexamethasone compared with aflibercept in naïve diabetic macular edemaTornado plot. The time horizon and the chosen extrapolation method, the source for dexamethasone efficacy, and the number of aflibercept injections are the key model drivers, with greater impact on the cost-effectiveness resultsBack to article page